A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of Irbesartan and Atorvastatin in combination as HCP0912

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hanmi Pharmaceutical Company Limited
• Treatments: Atorvastatin; Atorvastatin Calcium; Irbesartan

Criteria

Inclusion Criteria:

• Age between 20 and 45

• Signed informed consent form

• weight : over 45kg and in the range of ±20% of IBW

Exclusion Criteria:

• Has a medical history of hypersensitivity to atorvastatin or irbesartan

• severe Hypotension

• Not eligible for subject in health examination within 28 days of IP administration